Covista Inc. (CVSA) Stock Analysis

Q: What is the CVSA stock price target?

Take-profit $130.69 (+15.6% upside). Target $130.69 (+15.2%), stop $105.12 (−7.9%), A.R:R 2.2:1.

Q: What are the risks of investing in CVSA?

Earnings in 6 days (event risk); Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend); Momentum score 3.5/10 — below 4.5 minimum; Death cross — 50-day MA below 200-day MA.

Q: Is CVSA overvalued or undervalued?

Covista Inc. trades at a P/E of 17.0 (forward 13.2). TrendMatrix value score: 7.7/10. Overall verdict: Hold.

Q: What do analysts say about CVSA?

10 analysts cover CVSA with a consensus score of 4.3/5. Average price target: $154.

Range Bound setup

HoldModerate ConfidenceUpdated 2026-05-01

Consumer Defensive · Education & Training Services

Earnings in 6 days (2026-05-07). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $113.45, but acceptable to hold if already in. Reasons: Earnings in 6 days (event risk); Negative momentum.

Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make... Read more

$113.45+15.6% A.UpsideScore 5.6/10#8 of 15 Education & Training Services

Stop $105.12Target $130.69(analyst − 15%)A.R:R 2.2:1

Analyst target$153.75+35.5%4 analysts

$130.69our TP

$113.45price

$153.75mean

$175

Hold if already holding. Not a fresh buy at $113.45, but acceptable to hold if already in. Reasons: Earnings in 6 days (event risk); Negative momentum. Chart setup: RSI 50 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 5.6/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 6d<=7d. Suitability: aggressive.

Thesis

Rewards

Strong earnings beat streak (4/4)

Attractive valuation

Risks

Earnings in 6 days (event risk)

Negative momentum

Below 200-MA, MA slope -1.1%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)17.0

P/E (Fwd)13.2

Mkt Cap$4.0B

EV/EBITDA10.8

Profit Mgn13.4%

ROE18.0%

Rev Growth12.4%

Beta0.63

DividendNone

Rating analysts10

Quality Signals

Piotroski F8/9

Options Flow

P/C0.67bullish

IV75%elevated

Material Events(8-K, last 90d)

2026-03-03Item 1.02MEDIUM
**Delaware** | **001-13988** | **36-3150143** (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | | **233 South Wacker Drive** **Chicago****,****IL** | | **60606** (Address of principal executive offices) | | (Zip Code) **(****312****)...
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value7.715%1.16

Quality6.815%1.02

Growth4.215%0.63

Momentum3.510%0.35

Sentiment6.210%0.62

Insider Activity5.010%0.50

Peer Rank4.010%0.40

Technical Setup5.15%0.26

Risk Profile6.15%0.30

Catalyst7.15%0.35

Overall (Σ contributions)5.59

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd

0.0

Volume

0.0

Ma Position

3.0

Rsi

4.5

Obv

10.0

Volume accumulation (rising OBV)Below 200-MA, MA slope -1.1%/30d — confirmed downtrend

GatesMomentum 3.5<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 6d<=7dA.R:R 2.2 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive

RSI

50 · Neutral

↓ 20D MA↑ 50D MA↓ 200D MADEATH CROSSSupport $105.67Resistance $119.23

Price Targets

$105

$131

A.Upside+15.2%

A.R:R2.2:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Momentum score 3.5/10 — below 4.5 minimum

! Death cross — 50-day MA below 200-day MA

! EARNINGS_PROXIMITY:6d<=7d

Earnings

4/4 beats

Next Earnings2026-05-07 (6d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is CVSA stock a buy right now?

Hold if already holding. Not a fresh buy at $113.45, but acceptable to hold if already in. Reasons: Earnings in 6 days (event risk); Negative momentum. Chart setup: RSI 50 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $130.69 (+15.2%), stop $105.12 (−7.9%), A.R:R 2.2:1. Score 5.6/10, moderate confidence.

What is the CVSA stock price target?

Take-profit target: $130.69 (+15.6% upside). Target $130.69 (+15.2%), stop $105.12 (−7.9%), A.R:R 2.2:1. Stop-loss: $105.12.

What are the risks of investing in CVSA?

Earnings in 6 days (event risk); Negative momentum; Below 200-MA, MA slope -1.1%/30d (confirmed downtrend).

Is CVSA overvalued or undervalued?

Covista Inc. trades at a P/E of 17.0 (forward 13.2). TrendMatrix value score: 7.7/10. Verdict: Hold.

What do analysts say about CVSA?

10 analysts cover CVSA with a consensus score of 4.3/5. Average price target: $154.

What does Covista Inc. do?Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse...